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Abstract
Nociceptin/orphanin FQ (N/OFQ) is known to induce food intake when administered into the lateral ventricle or certain
brain areas. This is somewhat contradictory to its reward-suppressing role, as food is a strong rewarding stimulus. This
discrepancy may be due to the functional diversity of N/OFQ’s target brain areas. N/OFQ has been shown to inhibit orexin
and melanin-concentrating hormone (MCH) neurons, both of which are appetite-inducing cells. As the expression of these
neurons is largely confined to the lateral hypothalamus/perifornical area (LH/PFA), we hypothesized that N/OFQ inhibits
food intake by acting in this area. To test this hypothesis, we examined the effect of local N/OFQ infusion within the LH/PFA
on food intake in the rat and found that N/OFQ decreased sugar pellet as well as chow intake. This effect was not seen when
the injection site was outside of the LH/PFA, suggesting a site-specific effect. Next, to determine a possible cellular
mechanism of N/OFQ action on food intake, whole cell patch clamp recordings were performed on rat orexin neurons. As
previously reported in mice, N/OFQ induced a strong and long lasting hyperpolarization. Pharmacological study indicated
that N/OFQ directly inhibited orexin neurons by activating ATP-sensitive potassium (KATP) channels. This effect was partially
but significantly attenuated by the inhibitors of PI3K, PKC and PKA, suggesting that the N/OFQ signaling is mediated by
these protein kinases. In summary, our results demonstrate a KATP channel-dependent N/OFQ signaling and that N/OFQ is
a site-specific anorexic peptide.
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Introduction
The rewarding nature of food can induce caloric intake in
excess of our energy requirements by engaging the brain’s reward
circuitry in a manner not unlike drugs of abuse [1–3]. Such
excessive caloric intake is a major cause of obesity and its
comorbidities. Given the clear link between overfeeding and
obesity, understanding the neural underpinnings of reward-related
feeding is paramount.
Endogenous opioids are known for their critical role in the
brain’s reward system mediating the responses to substances of
abuse [4] and palatable foods [5]. Nociceptin/orphanin FQ (N/
OFQ) is an endogenous opioid known to bind the N/OFQ
peptide (NOP) receptor [6] and to have anti-reward properties.
Specifically, it functionally opposes the actions of other endoge-
nous opioids on reward-related behavioural responding [7,8] and
decreases drug-induced dopamine release in the nucleus accum-
bens [9,10]. Despite the rewarding nature of food, however, N/
OFQ has been shown to induce, rather than inhibit, food intake
when injected into the lateral ventricle [11] or several brain nuclei
[12,13]. This paradox of N/OFQ’s anti-reward and pro-feeding
actions remains unresolved. A possible explanation is the
functional heterogeneity of brain areas and neuronal types that
mediate the N/OFQ effects.
The lateral hypothalamus/perifornical area (LH/PFA) is
regarded as a critical brain region involved in motivated
behaviours including feeding [3,14]. There are two populations
of peptidergic neurons that are expressed more or less exclusively
in this region, i.e. orexin and melanin-concentrating hormone
(MCH) neurons. Both of these neurons promote reward-related
behavioural responses [15,16] including palatable food intake
[17,18], suggesting that the reward-related functions of the LH/
PFA can be largely attributed to these neurons. At the cellular
level, N/OFQ induces a potent and reversible hyperpolarization
of MCH neurons by activating G-protein dependent inwardly
rectifying potassium (GIRK) channels [19]. Orexin neurons are
also inhibited by N/OFQ via activation of potassium current [20],
although the identity of the effector channel has yet to be
identified. Based on these studies demonstrating that N/OFQ
negatively regulates feeding neurons in the LH/PFA, we
hypothesized that the LH/PFA is the site that N/OFQ would
have an inhibitory effect on food intake.
Here, we tested the effect of intra-LH/PFA injection of N/OFQ
on food intake. Furthermore, we investigated the cellular
mechanism by which N/OFQ inhibits orexin neurons and
identified KATP currents as being responsible for the inhibition.
Our results support the idea that N/OFQ is an anti-reward
peptide which can act specifically in the LH/PFA to regulate
feeding.
Materials and Methods
All experiments were performed following the Canadian
Council on Animal Care Guidelines and as approved by the
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Memorial University Institutional Animal Care Committee.
Sprague Dawley rats were obtained from the breeding colony at
Memorial University. Animals were housed in a light and
temperature controlled room (L:D=12:12 h, lights on at 7:00
am, room temperature 2261uC).
Surgery and Behavioural Testing
Male-Sprague Dawley rats (250–300 g) were anesthetized with
isoflurane (4% induction, 2% maintenance). A stainless-steel guide
cannula (22-gauge; 0.028 in. OD, 0.022 in. ID) was implanted to
the right LH/PFA using the following coordinates: 2.9 mm
posterior and 1.2 mm lateral with respect to the bregma and
2.5 mm dorsal to the interaural line. Cannulae were fixed in place
with skull screws and dental cement. Animals were housed
individually and given a minimum of 5 days to recover from
surgery before experimentation. All rats had ad libitum access to
standard lab chow with the exception of testing days. Water was
available at all times.
On test days, chow was removed at 9:00 am in order to prevent
spontaneous food intake immediately prior to the test period. At
1:00 pm, rats were given free access to sucrose pellets (dustless
precision pellets, F0021, Bio-Serv). Immediately preceding the
presentation of the food, an injection cannula was inserted into the
pre-implanted guide cannula to inject either N/OFQ (10 nmol in
0.5 ml) or vehicle (0.5 ml, control) into the LH/PFA over 60 sec,
which was then left in place for an additional 30–60 sec to ensure
proper diffusion at the injection site. N/OFQ was dissolved in
sterile saline at the final concentration, made into aliquots and
frozen at 220uC until use. The amount of food intake was
measured at one and three hours post-injection. Chow was
returned to the animals following the experiments. Each rat
received paired injections, i.e. vehicle or drug application on two
experimental days separated by a non-experimental day. The
order of injections was alternated from animal to animal. The
effect of N/OFQ was analyzed relative to the response to vehicle
to account for variations among individual animals. In a separate
cohort of rats, the same protocol was followed except instead of
sugar pellets, intake of chow following vehicle or N/OFQ injection
was examined.
After the food intake experiments, animals were euthanized
with CO2 and 4% pontamine sky blue (0.5 ml) was injected via the
injection cannula to aid in the localization of cannula placement.
Brains were removed, fixed in 10% formalin overnight, cryopro-
tected in 20% sucrose, frozen and cut at 40 mm on a cryostat.
Cannula placements were determined under a light microscope by
two experimenters. Injections that fell completely within the area
where orexin and MCH neurons are concentrated (based on [21])
were considered successful (on-target), whereas those with the
injection site completely outside of the field were considered as off-
target and served as a control group. Those with cannula
placements at the borderline of the orexin/MCH field were
excluded from the analysis.
In vitro Electrophysiology
Rats (60–70 g) were deeply anesthetised with halothane,
decapitated and brains were quickly removed. 250 mm-thick
coronal hypothalamic slices were generated in ice-cold artificial
cerebrospinal fluid (ACSF) using a vibratome (VT-1000, Leica
Microsystems). The composition of the ACSF was as follows (in
mM): 126 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 25
NaHCO3, 2 CaCl2, 10 glucose, pH 7.3–7.35. Following dissec-
tion, slices were incubated in ACSF at 32–35uC for 30–45 min,
then at room temperature until recording. ACSF was continuously
bubbled with O2 (95%)/CO2 (5%).
Conventional whole-cell patch-clamp recordings were per-
formed on brain slices perfused with ACSF at 1.5–2 ml/min,
2661uC, using a Multiclamp 700B amplifier and pClamp 9.2
software (Molecular Devices, Sunnyvale, CA). Slices were visual-
ized with a microscope equipped with infrared-differential in-
terference contrast optics (DM-LFSA, Leica Microsystems), to
target neurons with large cell-bodies (.15 mm diameter) and
located within the LH/PFA dorsal to the fornix. To increase the
extracellular K+ concentration to 10 mM, 7.5 mM of NaCl in
ACSF was replaced by KCl. Pipette resistance when filled with
internal solution ranged from 3 to 7 MV. Three different
conventional whole cell internal solutions were used in the present
study. The first one contained (in mM): 123 K-gluconate, 2
MgCl2, 8 KCl, 0.2 EGTA, 10 HEPES, 4 Na2-ATP, 0.3 Na-GTP.
For the high-chloride internal solution, K-gluconate was replaced
with equimolar KCl. Another conventional whole cell solution
used in the present study consisted of (in mM) 120 K-gluconate, 1
NaCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 10 EGTA, 3 K2ATP. For
perforated patch recordings, nystatin (final concentration 450 mg/
ml) and pluronic acid were dissolved in DMSO and added to an
internal solution that contained the following: 120 K-gluconate, 5
MgCl2, 10 EGTA, 40 HEPES. KOH was added to all internal
solutions until pH 7.3–7.35 was reached. Upon attaining whole
cell access (series resistance 10–25 MV), each neuron’s electro-
physiological characteristics were observed by applying a series of
300 msec hyperpolarizing (2200 and 2100 pA) and depolarizing
(100 and 200 pA) current injections in current clamp mode.
Voltage responses typical of orexin neurons included a lack of
spike adaptation upon positive current injection, the presence of
spontaneous action potentials, Ih and rebound depolarization upon
relief from hyperpolarizing steps [22]. Only cells displaying these
electrophysiological characteristics were included in the present
study. Voltage clamp experiments were performed at a holding
potential of 270 mV with the exception of voltage ramps, in
which the membrane potential was ramped from 2140 to
220 mV in 600 msec. Miniature excitatory postsynaptic currents
(mEPSCs) were recorded with tetrodotoxin (TTX, 1 mM) and
picrotoxin (50 mM) added to the ACSF. Series resistance was
monitored throughout the experiment by regularly applying
100 msec,220 mV square pulses. The resulting transient currents
were blanked in the representative voltage clamp traces in figures
for clarity of presentation. Cells in which the series resistance
changed by .20% during the course of the experiment were not
included for analysis.
All compounds were applied through the bath perfusion at the
final concentrations. TTX was obtained from Alomone Labs
(Jerusalem, Israel), picrotoxin and GDPbS were obtained from
Sigma-Aldrich (St. Louis, MO). N/OFQ (1–13)NH2, UFP-101,
tertiapin Q and glibenclamide were obtained from Tocris
Bioscience (Ellisville, MO). N/OFQ (1–13)NH2 is a bioactive
metabolite of N/OFQ and was used in the present study as a NOP
receptor agonist. N/OFQ (1–13)NH2 is referred to as N/OFQ for
the remainder of the Methods and throughout the Results section.
Antagonists and channel inhibitors were applied for a minimum of
5 min before N/OFQ was tested. For kinase inhibitor experi-
ments, slices were incubated for more than an hour before being
transferred into the recording chamber, where they were
continuously perfused with the same inhibitor throughout the
experiment.
Post-Hoc Immunohistochemistry
Biocytin (1–1.5 mg/ml) was added to internal solutions for
a subset of recordings to label cells for post-hoc immunohisto-
chemical phenotyping. Immediately following recording, sections
Nociceptin Inhibits Food Intake
PLOS ONE | www.plosone.org 2 September 2012 | Volume 7 | Issue 9 | e45350
were fixed in 10% formalin for .16 hours, washed in PBS then
treated with a cocktail of goat anti-orexin A (1:1000–3000; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit anti-MCH
(1:1000–4000; Phoenix Pharmaceuticals, Belmont, CA, USA)
antibodies for 3 days at 4uC, followed by a cocktail of Cy3-
conjugated donkey anti-goat, Cy2-conjugated donkey anti-rabbit
and streptavidin-conjugated AMCA (1:500; Jackson ImmunoR-
esearch, West Grove, PA, USA). Stained sections were visualized
using a fluorescence microscope to detect MCH (Cy2), Orexin-A
(Cy3) and biocytin (AMCA). Among 37 neurons with the
electrophysiological profile typical of orexin neurons and filled
with biocytin, none were MCH-immunopositive, 31 were
confirmed to be orexin-A immunopositive, while 6 were negative
for orexin A (success rate of identifying orexin neurons 31/
37= 83.8%). These orexin A-negative cells were excluded from
analysis. Some of the immunonegative results may be explained by
technical difficulty associated with staining thick sections. The high
success rate agrees with previous work from our lab [23] that
orexin neurons can be reliably identified based on electrophysi-
ological characteristics. Thus, as stated earlier, anatomical and
electrophysiological features were used as the primary means to
distinguish orexin neurons for this study.
Data Analysis
Membrane potential and holding current were measured using
Clampfit 9.2 (Molecular Devices; Sunnyvale, CA) and miniature
excitatory postsynaptic potentials (mEPSCs) were analyzed using
MiniAnalysis (Synaptosoft; Decatur, GA). Current density was
calculated by dividing the measured current (pA) by the
membrane capacitance (pF). The statistical tests used included
one-way ANOVA with Dunnett’s post test for multiple group
comparisons and two-tailed paired and unpaired Student t-tests for
Figure 1. Intra-LH/PFA N/OFQ injection decreases palatable food intake. A: Coronal brain maps depicting the location of injections. Each
circle represents a rat used for the analysis. Filled and open circles were categorized as on- or off-target, respectively, relative to the orexin/MCH field.
Numbers on the left of each map indicate the posterior distance from the bregma based on the Rat Brain Atlas by Paxinos and Watson [57]. The brain
maps were modified from the images in the Atlas. B: N/OFQ significantly reduced the sugar pellet intake during the first hour (1 h) following an
injection into the LH/PFA (on-target) but not the 3h-total intake post-injection (filled bars). In contrast, N/OFQ injections outside of the LH/PFA (off-
target) did not affect the sugar pellet consumption (open bars). C: N/OFQ significantly reduced chow intake during the first hour (1 h) following an
injection into the LH/PFA (on-target) but not the 3h-total intake (filled bars). This effect was not seen when the injection was off-target. * p,0.05.
doi:10.1371/journal.pone.0045350.g001
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two-group comparisons. Kolmogorov-Smirnov tests were used for
mEPSC analysis. Data are expressed as mean 6 S.E.M. p,0.05
was considered significant.
Results
Effect of Intra LH/PFA N/OFQ on Food Intake
To determine a site-specific role of N/OFQ, we investigated
how the intake of sugar pellets is affected by a local N/OFQ
administration into the LH/PFA. When N/OFQ was injected at
a dose (10 nmol) shown to increase feeding in the ventromedial
nucleus or nucleus accumbens [13], this resulted in a significant
reduction in the sugar intake during the first hour of feeding
compared to vehicle injection (Fig. 1B, n = 10, p,0.05, paired t-
test). By the 3rd hour, the difference in pellet intake disappeared as
a group (n= 10, p.0.05, paired t-test). Nonetheless, 7 out of 10
animals tested consumed less (more than 20% reduction) during
the first 3 hours following N/OFQ compared to vehicle injection.
When the cannula placement was outside of the LH/PFA (off-
target), N/OFQ did not have any significant effect (n = 11,
p.0.05 for 1 h and 3 h post-injection, paired t-test). We also
found that in rats that received N/OFQ into the LH/PFA (on-
target), chow intake during the first hour post-injection was
significantly reduced compared to that after saline (Fig. 1C, n= 4,
p,0.05, paired t-test), while the difference became non-significant
after 3 hours (p.0.05, paired t-test). Again, N/OFQ had no effect
on the chow intake in animals whose injection site was outside of
the LH/PFA (off-target) (Fig. 1C, n = 10, p.0.05 for 1 h and 3 h
post-injection). These results suggest that the local action of N/
OFQ in the LH/PFA is to inhibit food intake in general.
N/OFQ Effect on Rat Orexin Neurons
Next, we used patch clamp recordings to determine the cellular
mechanism underlying the N/OFQ effect on orexin neurons. We
found that bath application (2–5 min) of N/OFQ (300 nM)
induced a robust and long-lasting hyperpolarization in rat orexin
neurons (-15.660.7 mV, n= 4, Fig. 2A), in agreement with
a previous study in mice [20]. This concentration was used for
the remaining electrophysiological experiments. In voltage clamp
mode, the N/OFQ effect was detected as an outward current in all
orexin neurons tested (n = 28, Fig. 2B, E) using four different
internal solutions (K gluconate-based with Na2-ATP, n= 16; K
gluconate-based with K2-ATP, n= 5; KCl-based, n = 3; nystatin-
perforated patch, n = 4). The input resistance for these cells was
518641 MV, which falls within the range of values previously
reported for the same measure in mouse orexin neurons [24–27].
The amplitude of the outward currents was similar regardless of
the internal solution used (p.0.05, one-way ANOVA), and thus
data were grouped together. The effect was TTX-insensitive (n = 8
with 1 mM TTX, n= 20 without TTX; p.0.05, unpaired t-test)
and abolished by the selective competitive NOP receptor
antagonist UFP-101 (1 mM; Fig. 2C, E, n= 5, p,0.01, Dunnett’s
Figure 2. N/OFQ inhibits orexin neurons via NOP receptor activation in the rat. A: N/OFQ hyperpolarizes orexin neurons. B: Representative
voltage clamp trace showing a TTX-insensitive outward current induced by N/OFQ application. C: N/OFQ-induced effect is significantly attenuated by
UFP-101. However, the effect persists in the presence of naloxone (E), indicating a specific activation of NOP receptors. D: N/OFQ is ineffective on
orexin neurons patched with GDPbS in the recording pipette. E: Grouped data is shown. Numbers in bars represent the number of cells examined in
each group. ** p,0.01, *** p,0.005 vs. N/OFQ.
doi:10.1371/journal.pone.0045350.g002
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test) but not naloxone, the antagonist for the classic opioid
receptors (10 mM; Fig. 2E, n= 4, p.0.05, Dunnett’s test). The N/
OFQ current was also significantly attenuated by postsynaptic
loading of the non-hydrolysable GDP analogue GDPbS (2 mM;
Fig. 2D, E, n = 6, p,0.005, Dunnett’s test). These results suggest
that N/OFQ directly activates G-protein coupled NOP receptors
on orexin neurons.
Using a voltage ramp protocol, the reversal potential of the N/
OFQ-induced current was examined, which was near the
theoretical potassium equilibrium potential of 2102.1 mV
(n= 5, Fig. 3A), again consistent with the mouse study [20]. We
further confirmed this to be potassium current by increasing the
extracellular potassium concentration by four-fold, which depolar-
ized the reversal potential close to its theoretical value of
266.3 mV (n= 4, Fig. 3A–C, p,0.0001 vs. standard ACSF,
Figure 3. N/OFQ activates KATP channels in orexin neurons. A: Current responses to voltage-ramps before (control; CTL) and during N/OFQ
application in 2.5 mM extracellular potassium. B: Subtraction of currents recorded in two conditions (N/OFQ - CTL) reveals an N/OFQ-induced current
(2.5 mM K+). Increasing the extracellular potassium concentration to 10 mM shifted the current-voltage relationship rightward. C. Grouped data
showing that the reversal potential of the N/OFQ current is dependent on the concentration of extracellular potassium. *** p,0.005. D-F: N/OFQ
responses are attenuated by BaCl2 (D) and glibenclamide (Glib) (E) but not tertiapin Q (TQ) (F). Grouped data are shown in (G). *** p,0.005, n.s. non-
significant vs. N/OFQ. Numbers in bars represent the number of cells examined in each group. H: Once N/OFQ current is induced, it is persistent and
retains Ba++ sensitivity even after a prolonged washout.
doi:10.1371/journal.pone.0045350.g003
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unpaired t-test). The lack of effect of the internal solution used on
the magnitude of the N/OFQ current is consistent with the small
variability of the potassium equilibrium potential for each of the
different internal solutions (range from 299.8 to 2102.1 mV). We
also found that the N/OFQ response was inhibited by 1 mM
BaCl2 (n = 7, Fig. 3D and G, p,0.005, Dunnett’s test), suggesting
the involvement of barium-sensitive inwardly-rectifying potassium
channels. These include GIRK and ATP-sensitive potassium
(KATP) channels, which can be blocked using tertiapin Q and
glibenclamide, respectively. Blocking KATP channels with
200 nM glibenclamide abolished the N/OFQ response (Fig. 3E
and G, n= 8, p,0.005 vs. N/OFQ alone, Dunnett’s test). In
contrast, in the presence of tertiapin Q at a concentration shown
to attenuate the N/OFQ-induced effect in MCH neurons
(100 nM) [19], N/OFQ was still capable of inducing an outward
current (Fig. 3F and G, n= 8, p.0.05 vs. N/OFQ alone,
Dunnett’s test). The N/OFQ current was persistent and did not
return to baseline even after an hour following agonist washout,
but remained sensitive to barium (Fig. 3H). Taken together, the
inhibitory effect of N/OFQ is mediated by prolonged activation of
KATP channels in orexin neurons.
KATP channels have been shown to be regulated by a variety of
protein kinases, including phosphatidylinositol 3-kinase (PI3K)
[28], protein kinase A (PKA) [29] and protein kinase C (PKC)
[30]. To determine the intracellular mediator(s) of N/OFQ-
induced KATP channel activation, we tested the effect of N/OFQ
on orexin neurons treated with wortmannin (Wort; 500 nM), H89
(10 mM) or calphostin C (CalC; 100 nM), inhibitors of PI3K, PKA
and PKC, respectively. As shown in Figure 4, we found that all
three kinase inhibitors partially but significantly attenuated the
effect of N/OFQ (p,0.001, one-way ANOVA). Co-treatment
with CalC and H89 suppressed the N/OFQ current (n = 5,
p,0.05 vs. N/OFQ alone, Dunnett’s test) but did not show an
additive effect. These results suggest that PI3K, PKA and PKC
play a role in the activation of KATP channels by N/OFQ.
To determine whether N/OFQ has an additional effect on the
excitatory synaptic transmission, we examined its effect on
mEPSCs. We found that in 2 of the 8 cells examined, there was
a significant and reversible decrease in mEPSC inter-event interval
(p,0.05, Kolmogorov–Smirnov test) without a change in ampli-
tude (p.0.05, Kolmogorov–Smirnov test). However, as a group,
N/OFQ affected neither the interevent interval (n = 8, p.0.05,
Figure 4. N/OFQ-induced KATP channel activation is mediated by PI3K, PKA and PKC. A-E: Representative recordings showing the effect
of N/OFQ in the presence of specific inhibitors for PI3K (wortmannin; Wort), PKA (H89) or PKC (calphostin C; CalC), as indicated. Scale bars in A apply
to all traces. F: Grouped data showing that kinase inhibitors attenuate the N/OFQ effect. Combined application of H89 and CalC did not have an
additive effect. Numbers in bars represent the number of cells examined in each group. * p,0.05, *** p,0.001 vs. N/OFQ.
doi:10.1371/journal.pone.0045350.g004
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paired t-test) nor the amplitude of mEPSCs (n= 8, p.0.05, paired
t-test) (Fig. 5). Thus, in the rat, the presynaptic modulation by N/
OFQ only occurs in a minor subpopulation of orexin neurons.
Discussion
Previous studies have shown that N/OFQ inhibits orexin
neurons in vivo [31] and in vitro [20]. Here, we have extended
these findings to show that N/OFQ hyperpolarizes orexin neurons
by inducing a prolonged activation of KATP channels which is
mediated by PKA, PKC and PI3K. In contrast to the previous
report by Xie et al. [20], we found no effect of N/OFQ on
excitatory synaptic transmission in the majority of orexin neurons
tested. This may be due to differences in animal models as Xie and
colleagues utilized orexin/EGFP and orexin/YC2.1 transgenic
mice of both sexes while we used male rats. The composition of
internal solutions also differed but this is unlikely to account for the
discrepancy as the reported effect on excitatory transmission is
presynaptic, not postsynaptic [20]. Nonetheless, our work confirms
a robust and direct inhibitory effect which solidifies N/OFQ as
a negative regulator of orexin neurons, which may be involved in
the hypophagic action of N/OFQ in the LH/PFA.
N/OFQ Activates KATP Channels in Orexin Neurons
N/OFQ activates inwardly rectifying potassium channels in
a number of neuronal populations, some of which have
demonstrated barium sensitivity [32–36]. These characteristics
have been occasionally interpreted as GIRK currents since NOP
receptors are G protein coupled. However, the availability of
specific GIRK and KATP channel blockers allowed us to
determine that NOP receptor activation results in KATP currents
in orexin neurons (current study) and GIRK currents in MCH
neurons [19], both of which are barium sensitive. Therefore, the
barium sensitivity and inward rectification without the use of
specific inhibitors are insufficient to demonstrate GIRK channel
activation.
Our data suggest that in orexin neurons, NOP receptors
partially signal via PI3K, PKA and PKC, as has been shown in
other cell types [37–40]. Furthermore, each of these kinases has
been implicated in the regulation of KATP currents [28–30,41]. It
appears that there is some overlap in the signaling by these kinases
as the average inhibition of N/OFQ-induced currents by
wortmannin, H89 and calphostin C was 38.1, 44.5 and 58.5%
of control, respectively, which add up to be 141.1%. Should they
act independently, the added figure should not exceed 100%.
Furthermore, co-application of PKA and PKC inhibitors did not
induce an additive effect. This result indicates that PKA and PKC
signaling may converge onto a common signaling molecule such as
mitogen-activated protein kinase [42], which in turn can activate
KATP channels [43]. Alternatively, PKA and PKC may comprise
a single sequential signaling pathway, for example by PKA
activating PI3K [44] followed by lipid products of PI3K activating
PKC [45]. PI3K can also be activated independently by NOP
receptors since PI3Kc, a member of class 1B PI3K, is a major
effector of Gbc subunits {Leopoldt, 1998 2117/id}.
The source of endogenous N/OFQ released in the LH/PFA
remains unknown, since N/OFQ is expressed in a wide range of
brain areas [47] including those that send projections to the orexin
field [48]. Many N/OFQ-immunopositive fibers are found in the
hypothalamus, some of which make apparent synaptic contacts
with orexin neurons [20,31]. It is likely that some of these fibers
originate from orexin neurons as they co-express N/OFQ [49]
and synapse onto one another [50]. Our study showing a persistent
effect of N/OFQ which outlasts prolonged agonist washout
suggests that N/OFQ provides a tonic inhibitory tone that may be
important for preventing overexcitation from converging excit-
atory inputs that stimulate orexin neurons [51]. The time course of
the N/OFQ effect adds another layer of complexity associated
with cotransmission of orexin and opioids (dynorphin and N/
OFQ) by orexin neurons, since the balance between excitatory
and inhibitory actions of orexin and dynorphin, which have
different desensitization rates, has been shown to shift with time
[52].
Physiological Significance
N/OFQ has been known to elicit feeding when injected into
a number of brain sites, including the lateral ventricles,
ventromedial and arcuate hypothalamic nuclei and nucleus
accumbens shell [11–13]. In contrast, we found that the local
Figure 5. N/OFQ does not consistently modulate excitatory
transmission to orexin neurons. A: mEPSC traces from a represen-
tative orexin neuron before (control: CTL) and during N/OFQ (0.3 mM,
5 min) application, showing a lack of effect. B-C: Cumulative frequency
(freq.) graphs for mEPSC interevent interval (C) and amplitude (D) for
the cell shown in A. Solid and broken lines represent CTL and N/OFQ
conditions, respectively. D-E: Grouped data (n = 8) of mEPSC interevent
interval (D) and amplitude (E) in control and N/OFQ.
doi:10.1371/journal.pone.0045350.g005
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injection of N/OFQ into the LH/PFA decreased the intake of
sugar pellets and chow. The LH/PFA is populated by orexin and
MCH neurons known to promote the consumption of drugs of
abuse [15,16], palatable food [17,18,53] as well as regular lab
chow [17,18,53,54]. This, together with the known anti-reward
properties of N/OFQ, suggests that orexin and MCH neurons
mediate the inhibitory effect of N/OFQ on the motivational
aspect of food intake.
N/OFQ acts as a functional ‘‘anti-opioid peptide’’ in nocicep-
tion [55], motor activity [56] and reward [7,8]. In addition, the
results of the present study extend this to include food intake. N/
OFQ’s inhibitory effects on stress-induced analgesia and food
intake can be attributed, at least partially, to its effect on orexin
neurons ([20,31] and present study). It remains to be seen whether
these functions are mediated by the same or distinct subgroups of
orexin neurons. Nonetheless, we found all orexin neurons tested to
invariably respond to N/OFQ with an outward current or
hyperpolarization, which was consistently abolished by KATP
channel blockers. This suggests that the sensitivity to N/OFQ is
a common feature of this peptidergic cell type and that the same
cellular mechanism may be involved in the analgesic and feeding
effects. Therefore, N/OFQ is an important modulator of the
orexin system.
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